ATE323486T1 - Verwendung des riluzols oder dessen salzen zur phophylaxe und behandlung der adrenoleukodystrophie - Google Patents
Verwendung des riluzols oder dessen salzen zur phophylaxe und behandlung der adrenoleukodystrophieInfo
- Publication number
- ATE323486T1 ATE323486T1 AT01940687T AT01940687T ATE323486T1 AT E323486 T1 ATE323486 T1 AT E323486T1 AT 01940687 T AT01940687 T AT 01940687T AT 01940687 T AT01940687 T AT 01940687T AT E323486 T1 ATE323486 T1 AT E323486T1
- Authority
- AT
- Austria
- Prior art keywords
- riluzole
- salts
- phophylaxis
- adrenoleucodystrophy
- treatment
- Prior art date
Links
- FTALBRSUTCGOEG-UHFFFAOYSA-N Riluzole Chemical compound C1=C(OC(F)(F)F)C=C2SC(N)=NC2=C1 FTALBRSUTCGOEG-UHFFFAOYSA-N 0.000 title abstract 2
- 229960004181 riluzole Drugs 0.000 title abstract 2
- 201000011452 Adrenoleukodystrophy Diseases 0.000 abstract 1
- 102000009030 Member 1 Subfamily D ATP Binding Cassette Transporter Human genes 0.000 abstract 1
- 108010049137 Member 1 Subfamily D ATP Binding Cassette Transporter Proteins 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Treatments Of Macromolecular Shaped Articles (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0007162A FR2809620B1 (fr) | 2000-06-05 | 2000-06-05 | Utilisation du riluzole ou ses sels pour la prevention et le traitement de l'adrenoleucodystrophie |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE323486T1 true ATE323486T1 (de) | 2006-05-15 |
Family
ID=8850967
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01940687T ATE323486T1 (de) | 2000-06-05 | 2001-06-05 | Verwendung des riluzols oder dessen salzen zur phophylaxe und behandlung der adrenoleukodystrophie |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP1299102B1 (de) |
| JP (1) | JP4848117B2 (de) |
| AT (1) | ATE323486T1 (de) |
| AU (2) | AU2001274195B2 (de) |
| CA (1) | CA2409379C (de) |
| CY (1) | CY1107048T1 (de) |
| DE (1) | DE60118924T2 (de) |
| DK (1) | DK1299102T3 (de) |
| ES (1) | ES2260230T3 (de) |
| FR (1) | FR2809620B1 (de) |
| IL (2) | IL152989A0 (de) |
| MX (1) | MXPA02011810A (de) |
| PT (1) | PT1299102E (de) |
| WO (1) | WO2001093802A2 (de) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5728728A (en) * | 1996-04-10 | 1998-03-17 | Kozachuk; Walter E. | Methods of providing neuroprotection |
| CA2317811A1 (en) * | 1998-01-09 | 1999-07-15 | Mor-Research Applications Ltd. | Treatment of dyskinesias |
| EP1065931A4 (de) * | 1998-04-02 | 2006-10-11 | Avicena Group Inc | Eine kombination einer kreatin-verbindung und eines zweiten stoffes enthaltende zusammensetzungen |
-
2000
- 2000-06-05 FR FR0007162A patent/FR2809620B1/fr not_active Expired - Fee Related
-
2001
- 2001-06-05 WO PCT/FR2001/001729 patent/WO2001093802A2/fr not_active Ceased
- 2001-06-05 ES ES01940687T patent/ES2260230T3/es not_active Expired - Lifetime
- 2001-06-05 JP JP2002501376A patent/JP4848117B2/ja not_active Expired - Fee Related
- 2001-06-05 PT PT01940687T patent/PT1299102E/pt unknown
- 2001-06-05 DE DE60118924T patent/DE60118924T2/de not_active Expired - Lifetime
- 2001-06-05 IL IL15298901A patent/IL152989A0/xx unknown
- 2001-06-05 AT AT01940687T patent/ATE323486T1/de active
- 2001-06-05 EP EP01940687A patent/EP1299102B1/de not_active Expired - Lifetime
- 2001-06-05 AU AU2001274195A patent/AU2001274195B2/en not_active Ceased
- 2001-06-05 MX MXPA02011810A patent/MXPA02011810A/es active IP Right Grant
- 2001-06-05 DK DK01940687T patent/DK1299102T3/da active
- 2001-06-05 AU AU7419501A patent/AU7419501A/xx active Pending
- 2001-06-05 CA CA002409379A patent/CA2409379C/fr not_active Expired - Fee Related
-
2002
- 2002-11-20 IL IL152989A patent/IL152989A/en not_active IP Right Cessation
-
2006
- 2006-07-12 CY CY20061100968T patent/CY1107048T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1299102B1 (de) | 2006-04-19 |
| JP2003535113A (ja) | 2003-11-25 |
| IL152989A (en) | 2009-08-03 |
| ES2260230T3 (es) | 2006-11-01 |
| AU7419501A (en) | 2001-12-17 |
| EP1299102A2 (de) | 2003-04-09 |
| CA2409379A1 (fr) | 2001-12-13 |
| FR2809620A1 (fr) | 2001-12-07 |
| WO2001093802A2 (fr) | 2001-12-13 |
| DE60118924T2 (de) | 2007-01-11 |
| CA2409379C (fr) | 2009-08-18 |
| DK1299102T3 (da) | 2006-08-14 |
| CY1107048T1 (el) | 2012-09-26 |
| DE60118924D1 (de) | 2006-05-24 |
| JP4848117B2 (ja) | 2011-12-28 |
| PT1299102E (pt) | 2006-08-31 |
| MXPA02011810A (es) | 2004-05-17 |
| WO2001093802A3 (fr) | 2002-03-07 |
| AU2001274195B2 (en) | 2005-12-01 |
| IL152989A0 (en) | 2003-06-24 |
| FR2809620B1 (fr) | 2002-08-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60114580D1 (de) | Verwendung von cyanochinolinen zur behandlung oder inhibierung von dickdarmpolypen | |
| DE69938179D1 (de) | Kombination von riluzol und levodopa zur behandlung von morbus parkinson | |
| ATE527022T1 (de) | Verwendung von cyclooxygenase-2-inhibitoren zur behandlung und vorbeugung von tumoren, von tumor- abhängigen erkrankungen und kachexie | |
| DE60324777D1 (de) | Verwendung von il-18-inhibitoren zur behandlung und/oder prävention von peripheren gefässkrankheiten | |
| ATE555803T1 (de) | Verwendung von osteopontin zur behandlung und/oder vorbeugung von neurologischen erkrankungen | |
| DE60312736D1 (de) | 1,2,4-triaminobenzolderivate zur behandlung von erkrankungen des zentralnervensystems | |
| PL310475A1 (en) | Application of anticonvulsants in treating neuro-aids diseases | |
| DE69913548D1 (de) | Mglur5 antagonisten zur behandlung von schmerzen und angstzuständen | |
| DE60117046D1 (de) | Kombination von fenofibrat und von coenzym q10 für die behandlung der endotheliaal missfunktion | |
| DE60134009D1 (de) | Verwendung von il-18 inhibitoren zur behandlung und/oder prävention von atherosklerose | |
| BR0112212A (pt) | Uma combinação de inibidores de fbpase e agentes antidiabéticos úteis para o tratamento de diabetes | |
| DE50114605D1 (de) | No-thien-2-yl-essigsaure-derivate und ihre verwendung zur behandlung von migraine bzw. schmerz | |
| ATE332688T1 (de) | Verwendung von carbinolen zur behandlung von neuropathischer funktionsstörung | |
| ATE359808T1 (de) | Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma | |
| ATE264101T1 (de) | Verwendung von thioamidoxazolidinonen zur behandlung von knochenresorption und osteoporose | |
| ATE294584T1 (de) | Verwendung von desoxypeganin zur behandlung von alzheimerischer demenz | |
| DK1133296T3 (da) | Ny terapeutisk anvendelse af nicergolin | |
| ATE419851T1 (de) | Verwendung von riluzol zur behandlung multipler sklerose | |
| DE60118924D1 (de) | Verwendung des riluzols oder dessen salzen zur phophylaxe und behandlung der adrenoleukodystrophie | |
| NO20012777D0 (no) | Anvendelse av riluzol ved behandling av akustiske traumer | |
| ATE302009T1 (de) | Ubichinon qn zur behandlung von migräneschmerzen | |
| DE69936779D1 (de) | Verwendung von ngali nussöl zur behandlung/linderung der arthritisschmerzen und anderer ähnlichen störungen | |
| DE69906701D1 (de) | Topische verwendung von loperamid zur behandlung mikrobieller infektionen | |
| DE59910542D1 (de) | Verwendung von diminazen-di-aceturat und/oder pentamidin zur behandlung von malaria | |
| DE60111571D1 (de) | Verwendung von anethol-dithiolethion zur vorbeugung und behandlung der sehnentoxizität |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1299102 Country of ref document: EP |